We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AMTX market cap is 208.14M. The company's latest EPS is USD -0.9334 and P/E is -4.44.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 2.15M | 45.11M | 68.69M | 70.76M | 72.63M |
Operating Income | -12.12M | -7.79M | -8.53M | -8.96M | -9.46M |
Net Income | -26.41M | -25.28M | 30.71M | -25.44M | -24.23M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 202M | 165.56M | 211.95M | 256.51M | 186.72M |
Operating Income | -11.13M | -6.07M | -16.63M | -34.4M | -37.4M |
Net Income | -35.72M | -36.66M | -47.15M | -107.76M | -46.42M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 210.38M | 212.59M | 277.44M | 243.41M | 242.24M |
Total Liabilities | 432.8M | 451.52M | 477.43M | 460.38M | 474.38M |
Total Equity | -222.42M | -238.94M | -199.99M | -216.98M | -232.14M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 99.9M | 125.14M | 160.83M | 207.11M | 243.41M |
Total Liabilities | 254.27M | 309.88M | 281.07M | 408.97M | 460.38M |
Total Equity | -154.37M | -184.74M | -120.24M | -201.85M | -216.98M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -11.26M | -13.98M | -20.14M | 13.83M | -10.28M |
Investing | -859k | -2.51M | -10.91M | -23.69M | -1.68M |
Financing | 11.39M | 15.16M | 34.56M | 9.09M | 10.6M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -2.03M | 2.48M | -20.65M | -22.87M | 13.83M |
Investing | -8.58M | -17.31M | -22.89M | -31.31M | -23.69M |
Financing | 10.09M | 14.78M | 50.7M | 53.63M | 9.09M |
Market Cap | 208.14M |
Price to Earnings Ratio | -4.44 |
Price to Sales Ratio | 1.1 |
Price to Cash Ratio | 77.24 |
Price to Book Ratio | -0.95 |
Dividend Yield | - |
Shares Outstanding | 49.73M |
Average Volume (1 week) | 792.62k |
Average Volume (1 Month) | 878.39k |
52 Week Change | -11.89% |
52 Week High | 7.0299 |
52 Week Low | 2.16 |
Spread (Intraday) | 0.01 (0.24%) |
Company Name | Aemetis Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.aemetis.com |
Industry | industrial organic chemicals (2860) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions